Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for Apr. 17, 2014

April 17, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Cardica hopes to raise $44M in public offering

April 17, 2014 by Arezu Sarvestani

California surgical devices maker Cardica details a public offering of common and preferred stock aimed at raising $43.9 million to support U.S. sales and marketing efforts.

Cardica hopes to raise $44M in public offering

Cardica unveiled the details of an upcoming public offering of stock, aimed at raising $43.9 million to support commercial efforts for the company's MicroCutter XCHANGE 30 minimally invasive stapling system.

Cardiac Dimensions closes $20M equity round

April 17, 2014 by Brad Perriello

Cardiac Dimensions raises $20 million from a syndicate of international investors for its Carillon mitral valve implant.

Cardiac Dimensions closes $20M equity round

Cardiac Dimensions said it raised $20 million from a syndicate of international investors for its Carillon mitral valve implant.

M.H. Carnegie & Co. and Lumira Capital led the round for Kirkland, Wash.-based Cardiac Dimensions, according to a press release. Investors in Australia, the U.S. and Canada also participated, the company said.

Philips takes down Ohio manufacturing following inspection

April 17, 2014 by Arezu Sarvestani

Philips voluntarily suspends manufacturing at an Ohio facility after an FDA investigation turns up "certain issues in the general area of manufacturing process controls."

Philips takes down Ohio PET/CT manufacturing following inspection

Philips Healthcare (NYSE:PHG) halted work at an Ohio manufacturing facility after an FDA inspection turned up some concerns with process controls, a company spokesman confirmed with MassDevice.com today.

FDA warns Endo Health on AMS pelvic mesh plant

April 17, 2014 by Brad Perriello

The FDA sends a warning letter to Endo Health's American Medical Systems subsidiary over procedural violations at the Minnetonka, Minn., plant that makes pelvic mesh products.

FDA warns Endo Health on pelvic mesh plant

Endo Health Solutions (NSDQ:ENDP) said the FDA warned it about procedural violations at a Minnesota plant run by its American Medical Systems subsidiary that makes pelvic mesh products.

Baxter blows away Wall Street as renal sales surge in Q1

April 17, 2014 by Arezu Sarvestani

Baxter International's medical products division gets a major boost in the company's 1st quarter, pushing adjusted per-share earnings 9¢ above expectations.

Baxter blows away Wall Street with dialysis sales surge in Q1

Illinois healthcare titan Baxter (NYSE:BAX) isn't getting much Wall Street love today after posting Q1 adjusted per-share earnings that blew away expectations.

Mainstay Medical readies European IPO

April 17, 2014 by Brad Perriello

Mainstay Medical looks to raise up to $42 million with an initial public offering on the EuroNext stock exchange.

Mainstay Medical readies European IPO

Mainstay Medical is preparing an initial public offering on the EuroNext stock exchange that could be worth up to $42 million, according to a regulatory filing.

Mainstay, which last month launched a new clinical trial of its ReActiv8 implantable neurostimulator for chronic lower back pain, said it plans to offer some 1.1 million shares at €20-€27 per share, or about $27.77 to $37.50 per share.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp